Korea Joongang Daily on MSN
'A cancer relapse would be easier': Leukemia coverage catch-22 forces patients to abandon treatment
Korea’s five-year catastrophic illness rule is pushing chronic myeloid leukemia patients to stop lifelong treatment when ...
Recurrent Hodgkin lymphoma means the cancer returns after treatment and remission. In many cases, further treatments can help achieve remission or a possible cure. Hodgkin lymphoma (HL) is a type of ...
Recurrent C. diff infection is when you contract a C. diff infection 2 to 8 weeks after completing treatment for a previous one. C. diff relapse is a recurrence of the same strain, while reinfection ...
Researchers are investigating a potential vaccine that could help prevent certain cancers from returning. The vaccine, labeled the ELI-002 vaccine, appeared to reduce the risk of relapse in some ...
Algenomics, a company specializing in the development of ribonucleic acid (RNA)-based gene therapies, announced on June 15 ...
Physiologically Based Pharmacokinetic Model to Assess the Drug-Drug-Gene Interaction Potential of Belzutifan in Combination With Cyclin-Dependent Kinase 4/6 Inhibitors A total of 14,177 patients were ...
Morning Overview on MSN
Intismeran autogene plus Keytruda dropped melanoma recurrence by close to 50% over five years in a Moderna-Merck-NYU trial unveiled at ASCO
Patients with high-risk melanoma who received a personalized mRNA cancer vaccine alongside Keytruda saw their risk of disease recurrence drop by close to half over five years, according to updated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results